Your Search Returned 4 tagged news reports
alone has three drugs approved to treat the disease. NVS ) Afinitor that are all approved to treat the cancer at varying stages...With that many competitors, combining forces would seem to be a good move to increase efficacy, potentially
Pfizer Inc said on Friday that a late-stage trial of its drug for renal cell cancer failed to meet its main goal when given in combination with Avastin, a drug made by Roche Holding AG. Pfizer's drug Torisel is approved as a single agent for the
study of Torisel as second-line treatment in advanced renal cell carcinoma (RCC)...Overall survival, a secondary endpoint in the study, showed statistical significance favoring patients randomized to the sorafenib arm. The study reported consistent
The way to make money in biotech is to find companies going after unmet needs . The bar is lower for an approval and sales are easier without any competition. The corollary, then, is that the way to not make money is to invest in crowded markets...